Quick Answer
MAXCYTE, INC. reported Gross Profit of $26.80 million for fiscal year 2025.
MAXCYTE, INC. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $26.80M | -15.0% |
| 2024 | $31.53M | -13.7% |
| 2023 | $36.55M | -6.7% |
| 2022 | $39.16M | +29.5% |
| 2021 | $30.25M | +29.2% |
| 2020 | $23.40M | +22.4% |
| 2019 | $19.12M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.23M | -16.1% | -25.1% |
| June 30, 2025 | $6.99M | -21.8% | -21.4% |
| March 31, 2025 | $8.89M | -10.5% | +42.6% |
| September 30, 2024 | $6.24M | -13.5% | -30.3% |
| June 30, 2024 | $8.94M | +16.6% | -10.0% |
| March 31, 2024 | $9.94M | +31.2% | +37.8% |
| September 30, 2023 | $7.21M | -22.2% | -5.9% |
| June 30, 2023 | $7.67M | -9.7% | +1.2% |
- MAXCYTE, INC. showed a decrease of -15.0% in Gross Profit compared to the prior fiscal year.
- Over the 2019–2025 period, MAXCYTE, INC.’s gross profit has grown by 40.2% (from $19.12 million to $26.80 million).
- The most recent figure is from MAXCYTE, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: